Showing results (3761-3770 of 5,049) with videos related to
Sort By:
Pageof 505
Headache|November 5, 2026
Comparative efficacy of vitamins and nutraceuticals for migraine prevention: A systematic review and network meta-analysis of randomized controlled trialsMuhammad Ahmed, Ume Aiman, Niraj Kukreja, et al.Headache|May 7, 2022
Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo-controlled randomized clinical trialsJack D Schim, Carlton Anderson, Elizabeth Brunner, et al.Headache|November 24, 2022
The effect of the COVID-19 pandemic on headache-related disability among young adults with migraineLauren Y Thaxter, Todd A SmithermanHeadache|October 22, 2020
Demographics, Headache Features, and Comorbidity Profiles in Relation to Headache Frequency in People With Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) StudyDawn C Buse, Michael L Reed, Kristina M Fanning, et al.Headache|October 16, 2020
E-Consultation in Headache Medicine: A Quality Improvement Pilot StudyJennifer Robblee, Amaal J StarlingHeadache|April 1, 2020
Two-Hour CGRP Infusion Causes Gastrointestinal Hyperactivity: Possible Relevance for CGRP Antibody TreatmentKatrine Falkenberg, Helene Rønde Bjerg, Jes OlesenHeadache|June 14, 2021
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) projectPiero Barbanti, Luisa Fofi, Licia Grazzi, et al.Headache|December 18, 2020
Characterizing the providers of and reimbursement for chronic migraine chemodenervation among the Medicare populationSina J Torabi, David A Kasle, Emily L Savoca, et al.Headache|December 16, 2020
A non-convulsant delta-opioid receptor agonist, KNT-127, reduces cortical spreading depression and nitroglycerin-induced allodyniaZachariah Bertels, Wiktor D Witkowski, Sarah Asif, et al.Pageof 505